AbbVie vs Dell: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Dell was founded in 1984 by Michael S. Dell and is led by Michael S. Dell.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Dell
Michael S. Dell
Dell Technologies possesses one of the most famous, foundational founding stories in the history of the personal computer revolution, rooted in an aggressive, direct-to-consumer arbitrage strategy executed entirely from a college dorm room.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Dell
- Michael S. Dell1984–present
Founder, Chairman, and Chief Executive Officer
Michael Dell's bold, aggressive strategic maneuvers transformed the company from a successful consumer PC manufacturer into a global leader in complex enterprise data center infrastructure and advanced cloud computing.
Source - Kevin Rollins2004–2007
President and Chief Executive Officer
As CEO from 2004 to 2007, he oversaw a period of severe stagnation, losing the company's #1 PC market share position to HP, forcing Michael Dell to return and retake control.
Source - Jeff Clarke2017–present
Vice Chairman and Chief Operating Officer
As Vice Chairman and Co-COO, he is the primary operational architect of Dell's Infrastructure Solutions Group, transforming the company from a PC maker into a massive enterprise IT vendor.
Source - David Kennedy2025–present
Chief Financial Officer
As Chief Legal Officer, he navigated the highly contentious 2013 leveraged buyout that took the company private, and the equally complex 2018 transaction that returned it to the public markets.
Source
Timeline: AbbVie and Dell side by side
1984Dell
PC's Limited Founded
Michael Dell starts PC's Limited from his University of Texas dorm room using a direct-sales PC model.
1988Dell
Dell Goes Public
Dell Computer Corporation completes its initial public offering and scales internationally.
2001Dell
Dell Becomes Largest PC Maker
Dell becomes the world's largest PC maker by market share, validating the direct model at global scale.
2007Dell
Michael Dell Returns as CEO
Michael Dell returned as chief executive in January 2007, replacing Kevin Rollins.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2013Dell
Dell Goes Private
Michael Dell and Silver Lake take Dell private in a leveraged buyout to reposition the company away from public-market pressure.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016Dell
EMC Acquired
Dell completes the EMC acquisition, creating Dell Technologies and expanding into enterprise storage, infrastructure, and VMware-linked assets.
2018Dell
Dell Returns to Public Markets
Dell Technologies returns to public-market trading through a complex transaction involving its VMware tracking stock.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021Dell
VMware Spin-Off
Dell completes the VMware spin-off, simplifying the corporate structure and reducing debt.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Dell
PC Brands Simplified
Dell introduces simplified Dell, Dell Pro and Dell Pro Max PC brand tiers at CES 2025.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Dell
Record $113.5B Fiscal Year
Dell reports record fiscal 2026 revenue of $113.5B, $64.1B of AI server orders and a $43B AI backlog.
2026Dell
$95B AI Server Backlog
Q2 fiscal 2027 revenue rises 58% to $47.0B; AI orders hit $60.9B and backlog reaches $95B; full-year guidance raised to about $192B.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Dell
- EMC Corporation2016$67B
- Quest Software2012$2.4B
- Perot Systems2009$3.9B
- Alienware2006Undisclosed
Questions about AbbVie vs Dell
Who is the CEO of AbbVie Inc. and Dell Technologies Inc.?
AbbVie Inc. is led by Robert A. Michael and Dell Technologies Inc. is led by Michael S. Dell. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Dell Technologies Inc.?
Dell Technologies Inc. was founded in 1984 — 29 years before AbbVie Inc., which was founded in 2013. Dell Technologies Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Dell Technologies Inc.?
AbbVie Inc. employs approximately 57,000 people, while Dell Technologies Inc. employs approximately 97,000. Dell Technologies Inc. has the larger workforce at 97,000 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Dell Technologies Inc. headquartered?
Both AbbVie Inc. and Dell Technologies Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Dell Technologies Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Dell Technologies Inc. was founded by Michael S. Dell.
Which company has a longer operating history — AbbVie Inc. or Dell Technologies Inc.?
Dell Technologies Inc. has been operating for approximately 42 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Dell overview